Protagenic Therapeutics' Unattributed - IV Round

Protagenic Therapeutics raised a round of funding on September 27, 2013.

Protagenic Therapeutics is a biotechnology company focusing on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorder…

Articles about Protagenic Therapeutics' Unattributed - IV Round: